Skip to main content
FinSpry Logo
FinSpry
PLX logo
PLX
(NYSEAMERICAN)
Protalix BioTherapeutics, Inc.
$2.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Protalix BioTherapeutics (PLX) Stock Price & Financial Analysis

Protalix BioTherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.90 - $2.03
52-Week High$3.19
52-Week Low$1.32
Open$1.90
Volume700.92K
Average Volume (3M)770.67K
Market Cap150.02M
Shares Outstanding78.55M
Price to Sales (P/S)2.95
Price to Book (P/B)3.22
EV/EBITDA-36.97
Revenue (TTM)52.74M
Net Income (TTM)-6.60M
Free Cash Flow (TTM)-13.63M
EPS (TTM)$-0.08
Profit Margin-12.52%
Operating Margin-10.43%
Return on Equity (ROE)-13.69%
Debt to Equity0.17
50-Day MA$2.30
200-Day MA$2.11
52-Week Change32.88%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Protalix BioTherapeutics

What is the current stock price for PLX?

As of the latest trading session, PLX stock trades at $2.01. The 52-week range is $1.32–$3.19, with a day range of $1.90–$2.03.

What is the P/E ratio for PLX?

The P/E ratio (Price-to-Earnings) for PLX is shown in the Key Statistics section. This valuation metric helps compare Protalix BioTherapeutics, Inc. to industry peers.

Does PLX pay dividends?

Protalix BioTherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PLX?

Based on 1 analyst, the consensus for PLX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PLX?

Protalix BioTherapeutics's market capitalization is $157.9M, classifying it as a micro-cap company. Protalix BioTherapeutics operates in the Healthcare sector within the Biotechnology industry.